vs

Side-by-side financial comparison of Comstock Holding Companies, Inc. (CHCI) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Comstock Holding Companies, Inc. is the larger business by last-quarter revenue ($23.9M vs $17.3M, roughly 1.4× Sol-Gel Technologies Ltd.). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs 56.3%, a 11.0% gap on every dollar of revenue. On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 41.5%).

The Comstock Lode is a lode of silver ore located under the eastern slope of Mount Davidson, a peak in the Virginia Range in Virginia City, Nevada, which was the first major discovery of silver ore in the United States and named after Canadian miner Henry Comstock.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

CHCI vs SLGL — Head-to-Head

Bigger by revenue
CHCI
CHCI
1.4× larger
CHCI
$23.9M
$17.3M
SLGL
Growing faster (revenue YoY)
SLGL
SLGL
+176.2% gap
SLGL
217.7%
41.5%
CHCI
Higher net margin
SLGL
SLGL
11.0% more per $
SLGL
67.3%
56.3%
CHCI

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CHCI
CHCI
SLGL
SLGL
Revenue
$23.9M
$17.3M
Net Profit
$13.5M
$11.6M
Gross Margin
35.5%
Operating Margin
32.4%
65.1%
Net Margin
56.3%
67.3%
Revenue YoY
41.5%
217.7%
Net Profit YoY
30.5%
487.6%
EPS (diluted)
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCI
CHCI
SLGL
SLGL
Q4 25
$23.9M
Q3 25
$13.3M
Q2 25
$13.0M
$17.3M
Q1 25
$12.6M
Q4 24
$16.9M
Q3 24
$13.0M
Q2 24
$10.8M
$5.4M
Q1 24
$10.6M
Net Profit
CHCI
CHCI
SLGL
SLGL
Q4 25
$13.5M
Q3 25
$541.0K
Q2 25
$1.4M
$11.6M
Q1 25
$1.6M
Q4 24
$10.3M
Q3 24
$2.4M
Q2 24
$946.0K
$2.0M
Q1 24
$910.0K
Gross Margin
CHCI
CHCI
SLGL
SLGL
Q4 25
35.5%
Q3 25
11.0%
Q2 25
19.0%
Q1 25
18.6%
Q4 24
33.4%
Q3 24
26.3%
Q2 24
17.2%
Q1 24
16.5%
Operating Margin
CHCI
CHCI
SLGL
SLGL
Q4 25
32.4%
Q3 25
5.0%
Q2 25
13.7%
65.1%
Q1 25
13.7%
Q4 24
30.1%
Q3 24
21.8%
Q2 24
11.4%
29.9%
Q1 24
10.8%
Net Margin
CHCI
CHCI
SLGL
SLGL
Q4 25
56.3%
Q3 25
4.1%
Q2 25
11.1%
67.3%
Q1 25
12.6%
Q4 24
61.1%
Q3 24
18.3%
Q2 24
8.8%
36.4%
Q1 24
8.6%
EPS (diluted)
CHCI
CHCI
SLGL
SLGL
Q4 25
Q3 25
Q2 25
$4.17
Q1 25
Q4 24
Q3 24
Q2 24
$0.71
Q1 24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCI
CHCI
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$31.3M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$70.0M
$31.9M
Total Assets
$85.0M
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCI
CHCI
SLGL
SLGL
Q4 25
$31.3M
Q3 25
$26.2M
Q2 25
$30.5M
$24.3M
Q1 25
$28.3M
Q4 24
$28.8M
Q3 24
$21.1M
Q2 24
$17.4M
$26.5M
Q1 24
$16.2M
Stockholders' Equity
CHCI
CHCI
SLGL
SLGL
Q4 25
$70.0M
Q3 25
$56.3M
Q2 25
$55.5M
$31.9M
Q1 25
$53.7M
Q4 24
$52.4M
Q3 24
$41.7M
Q2 24
$39.2M
$34.9M
Q1 24
$37.9M
Total Assets
CHCI
CHCI
SLGL
SLGL
Q4 25
$85.0M
Q3 25
$67.6M
Q2 25
$65.2M
$39.3M
Q1 25
$62.8M
Q4 24
$64.9M
Q3 24
$52.2M
Q2 24
$48.6M
$42.0M
Q1 24
$46.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCI
CHCI
SLGL
SLGL
Operating Cash FlowLast quarter
$4.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.36×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCI
CHCI
SLGL
SLGL
Q4 25
$4.8M
Q3 25
$-3.2M
Q2 25
$2.2M
Q1 25
$582.0K
Q4 24
$10.7M
Q3 24
$3.9M
Q2 24
$1.3M
Q1 24
$-2.2M
Cash Conversion
CHCI
CHCI
SLGL
SLGL
Q4 25
0.36×
Q3 25
-5.96×
Q2 25
1.51×
Q1 25
0.37×
Q4 24
1.03×
Q3 24
1.63×
Q2 24
1.35×
Q1 24
-2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHCI
CHCI

Related Party$22.1M92%
Nonrelated Party$1.9M8%

SLGL
SLGL

Segment breakdown not available.

Related Comparisons